Skip to content

Effects of Remimazolam and Etomidate at Different Doses on Hemodynamics in Elderly Patients After Induction Monitored by Non-invasive Cardiac Output Monitor

Effects of Remimazolam and Etomidate at Different Doses on Hemodynamics in Elderly Patients After Induction Monitored by Non-invasive Cardiac Output Monitor

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115244
Enrollment
Unknown
Registered
2025-12-24
Start date
2026-01-10
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Low Remimazolam Group:None
Medium Remimazolam Group:None
High Remimazolam Group:None

Sponsors

The First People's Hospital of Changzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Elderly patients aged 65 years and above who are scheduled for elective surgery. 2.American Society of Anesthesiologists (ASA) Physical Status Classification ?–?.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiopulmonary function impairment. 2. Patients allergic to any drugs used in this trial. 3. Patients with diseases such as mental illness, cognitive impairment, severe hypertension, diabetes mellitus, pheochromocytoma, or uncontrolled hyperthyroidism. 4. Patients who have taken analgesic or sedative drugs recently.

Design outcomes

Primary

MeasureTime frame
Stroke Volume;Cardiac Output;Systemic Vascular Resistance;Left Ventricular Stroke Work;Mean Arterial Pressure;Heart Rate;Emergence Time;Post-Anesthesia Care Unit Stay Time;ncidence of Adverse Cardiovascular Events;Incidence of Postoperative Delirium;

Countries

China

Contacts

Public ContactGao Cao

The First People's Hospital of Changzhou

gjzszg@hotmail.com+86 138 0150 7929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026